Abstract
Baclofen† (Lioresal), a derivative of gamma-aminobutyric acid, was introduced in 1966 as a possible treatment for spasticity due to corticospinal tract lesions. Preliminary studies suggested that it may be more effective than other spasmolytic agents currently available, and a double-blind controlled trial in a group of 23 patients against placebo has shown it to be significantly more effective.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cook J. B., Nathan P. W. On the site of action of diazepam in spasticity in man. J Neurol Sci. 1967 Jul-Aug;5(1):33–37. doi: 10.1016/0022-510x(67)90005-6. [DOI] [PubMed] [Google Scholar]
- Curtis D. R., Watkins J. C. The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacol Rev. 1965 Dec;17(4):347–391. [PubMed] [Google Scholar]
- Jones R. F., Burke D., Marosszeky J. E., Gillies J. D. A new agent for the control of spasticity. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):464–468. doi: 10.1136/jnnp.33.4.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NATHAN P. W. Intrathecal phenol to relieve spasticity in paraplegia. Lancet. 1959 Dec 19;2(7112):1099–1102. doi: 10.1016/s0140-6736(59)90094-7. [DOI] [PubMed] [Google Scholar]
- Pedersen E., Arlien-Soborg P., Grynderup V., Henriksen O. Gaba derivative in spasticity. (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba). Acta Neurol Scand. 1970;46(3):257–266. doi: 10.1111/j.1600-0404.1970.tb05791.x. [DOI] [PubMed] [Google Scholar]